MYND Life Sciences Announces Stock Option Grant
Vancouver, British Columbia--(Newsfile Corp. - August 10, 2022) - Mynd Life Sciences Inc. (CSE: MYND) (OTCQB: MYNDF) ("Mynd" or the "Company"), a biopharmaceutical research and development company creating innovative precision medicines and diagnostic solutions for patients with relentless neurological diseases, announces a stock option grant pursuant to the Company's stock option plan. Stock Option GrantThe Company's Board of Directors has approved a stock options grant, exercisable to...
2022-08-10 11:00 AM EDT
Mynd Life Sciences Terminates Proposed Transaction with Tidal Psychedelics
Vancouver, British Columbia--(Newsfile Corp. - June 29, 2022) - Mynd Life Sciences Inc. (CSE: MYND) (OTCQB: MYNDF) ("Mynd" or the "Company") announces that it has terminated the non-binding memorandum of understanding ("MOU") to acquire all the issued and outstanding shares of Tidal Care Inc. o/a Tidal Psychedelics ("Tidal") as disclosed in Mynds's March 16, 2022 press release, due to differences in the strategic direction of the proposed acquisition. Mynd has advised Tidal of the termination...
2022-06-29 8:30 PM EDT
MYND Life Sciences Announces Chief Scientific Officer, Dr. Wilf Jefferies, Induction as a National Academy of Inventors Fellow
Vancouver, British Columbia--(Newsfile Corp. - June 17, 2022) - Mynd Life Sciences Inc. (CSE: MYND) (OTCQB: MYNDF) ("Mynd" or the "Company"), a biopharmaceutical research and development company creating innovative precision medicines and diagnostic solutions for patients with relentless neurological diseases, is pleased to announce that Dr. Wilfred Jefferies, Mynd's Chief Scientific Officer, has been inducted as a Fellow of the National Academy of Inventors. Globally, the most accomplished...
2022-06-17 9:00 AM EDT
MYND Life Sciences Announces New Testing Methodologies for Measuring Cellular Responses to Microdosing with Psilocybins
Vancouver, British Columbia--(Newsfile Corp. - June 1, 2022) - Mynd Life Sciences Inc. (CSE: MYND) (OTCQB: MYNDF) ("Mynd" or the "Company"), a biopharmaceutical research and development company creating innovative precision medicines and diagnostic solutions for patients with relentless neurological diseases, today announced positive preclinical data in measuring dosing accuracy in psilocybins and psilocybin analogs.Mynd strives to improve industry standards and promotes innovative research...
2022-06-01 9:00 AM EDT
MYND Life Sciences Announces $3.5 Million Share Offering
Vancouver, British Columbia--(Newsfile Corp. - April 21, 2022) - MYND Life Sciences Inc. (CSE: MYND) (OTCQB: MYNDF) ("MYND" or the "Company"), is pleased to announce that it plans to undertake a non-brokered private placement offering (the "Offering") of common shares in share capital of the Company ("Shares") to raise gross proceeds of a minimum of $3,000,000 up to $3,500,000, or such other amounts as may be determined by the Company.The Offering will close immediately after (and subject to...
2022-04-21 5:00 PM EDT
MYND Life Sciences Executes a Non-Binding MOU with Tidal Psychedelics
Vancouver, British Columbia--(Newsfile Corp. - March 16, 2022) - MYND Life Sciences Inc. (CSE: MYND) (OTCQB: MYNDF) ("MYND" or the "Company"), a biopharmaceutical research and development company creating innovative precision medicines for patients with relentless neurological diseases, today announced it has entered into a non-binding memorandum of understanding ("MOU") to acquire all the issued and outstanding shares of Tidal Care Inc. o/a Tidal Psychedelics ("Tidal"). Tidal is a vertically...
2022-03-16 9:00 AM EDT
MYND Life Sciences Inc. Announces the Recruitment of a Senior Operations and Research Manager
Vancouver, British Columbia--(Newsfile Corp. - March 9, 2022) - MYND Life Sciences Inc. (CSE: MYND) (OTCQB: MYNDF) ("MYND" or "the Company") announces the hiring of a Senior Operations and Research Manager and the resignation of a company officer.MYND is pleased to announce the hiring of Dr. Chaahat S.B Singh as the Company's Senior Operations and Research Manager. In 2019, Dr. Singh was awarded a PhD in Medical Genetics focusing on Central Nervous System (CNS) disorders at the University of...
2022-03-09 9:00 AM EST